Compare ETHM & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ETHM | FENC |
|---|---|---|
| Founded | 2024 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.1M | 263.3M |
| IPO Year | 2024 | 2001 |
| Metric | ETHM | FENC |
|---|---|---|
| Price | $10.34 | $7.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 94.3K | ★ 115.8K |
| Earning Date | 03-20-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $38,790,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $70.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.84 | $4.68 |
| 52 Week High | $15.24 | $9.92 |
| Indicator | ETHM | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 55.17 | 52.77 |
| Support Level | $10.32 | $7.55 |
| Resistance Level | $10.38 | $8.11 |
| Average True Range (ATR) | 0.02 | 0.30 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 60.00 | 60.79 |
Dynamix Corp is a blank check company.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.